Results 201 to 210 of about 33,193 (249)

A Review of Alpha-2 Adrenergic Agents Implicated in Opioid Use Disorder. [PDF]

ACS Chem Neurosci
Hannum A, Spano I, Ofori E.
europepmc   +1 more source

Identification of Subtype-Selective Binding Sites in the Opioid Receptor Family. [PDF]

J Chem Inf Model
S Gomes AA, Guillot B, Jelsch C, Giraldo J.   +3 more
europepmc   +1 more source

Seeing the bigger picture: endogenous opioids mediate attentional broadening after reward receipt. [PDF]

Psychol Med
van Steenbergen H, Gable P, Fagan H, Molteni L, Midveris A, Huneke N.   +5 more
europepmc   +1 more source

Aberrant type 2 dopamine and mu-opioid receptor availability in autism spectrum disorder. [PDF]

Eur J Nucl Med Mol Imaging
Noppari T, Tuisku J, Lukkarinen L, Tani P, Lindberg N, Saure E, Lauerma H, Tiihonen J, Hirvonen J, Helin S, Rajander J, Salmi J, Nummenmaa L.   +12 more
europepmc   +1 more source

Naloxegol, an Oral Peripherally Acting Opioid Receptor Antagonist, Administered Concurrently with First-Line Systemic Therapy for Advanced Lung Adenocarcinoma (Alliance A221504): A Feasibility and Safety Study. [PDF]

Cancers (Basel)
Gupta P, Gupta K, Dockter T, Harlos E, Chow S, Subbiah N, Ruddy KJ, Bazhenova L, Terstriep S, Huang CH, Kratzke RA, Vokes EE, Loprinzi CL.   +12 more
europepmc   +1 more source

Met-enkephalin modulates the stress responses of plasma concentrations of corticosterone, delta opioid receptor binding, pro-enkephalin expression, and processing in chickens. [PDF]

Front Physiol
Pierzchała-Koziec K, Scanes CG, Jaszcza K.   +2 more
europepmc   +1 more source

Investigating Opioid Receptor Activity through Biocatalytic Halogenation and Oxidation of Mitragynine. [PDF]

ACS Chem Biol
Harris NR, Powell AJ, Snodgrass HM, Amin S, Newmister SA, Curtis BJ, Li D, Husaini ZA, Verhey-Henke L, Smith JL, Pereira F, Lewis JC, Traynor J, Sherman DH.   +13 more
europepmc   +1 more source

Oxycodone: A Pain-Relieving Agent With Cardioprotective Properties Against Myocardial Ischemia-Reperfusion Injury. [PDF]

Cardiovasc Ther
Firoozabadi MD, Nooralishahi B, Rezaei-Tazangi F.   +2 more
europepmc   +1 more source

Complex opioid-driven modulation of glutamatergic and cholinergic neurotransmission in a GABAergic brain nucleus associated with emotion, reward, and addiction. [PDF]

Elife
Chittajallu R, Vlachos A, Caccavano AP, Yuan X, Hunt S, Abebe D, London E, Pelkey KA, McBain CJ.   +8 more
europepmc   +1 more source